Moderna
Moderna is a biotechnology company known for its mRNA-based medicines, including the COVID-19 vaccine Spikevax™, with a broad patent portfolio and global operations.
Moderna Services
Moderna provides mRNA medicines that are designed to direct the body's cells to produce proteins to prevent or fight diseases. The company's innovative platform enables rapid design, research, and testing of multiple mRNAs within days. Each mRNA medicine leverages these advancements, delivering solutions that do not contain animal products or preservatives.
Moderna Products
Moderna offers Spikevax™ (mRNA-1273 COVID-19 VACCINE) under various US patents. Beyond Spikevax™, the company boasts a diverse pipeline of vaccines and therapeutics across various stages of development. These products are designed to address a range of health conditions by engaging the body's cellular machinery.
Moderna Patents
Moderna holds a broad collection of patents and has several hundred additional pending patent applications. The company owns patents in the United States as well as in foreign jurisdictions. This intellectual property portfolio underpins its innovative mRNA-based medicines and allows for the protection and commercialization of its technologies.
Moderna Global Presence
Moderna maintains a global presence, with operations and websites tailored for various regions including Asia Pacific, Europe, North America, and South America. This extensive reach enables the company to serve diverse populations and collaborate with international partners, maximizing the impact of its mRNA technologies.
Moderna Strategic Collaborations
Moderna engages in strategic collaborations with other pharmaceutical and biotech companies, government organizations, foundations, and research institutes. These collaborations are vital to the progression of its mRNA medicines, facilitating advances in research, development, and distribution on a global scale.